Medication Reconciliation and Drug Regimen Review (Home Health)

It covers the full medication review workflow for a home visit: confirming the current medication sources, reconciling prescription and nonprescription items, screening for drug-drug and drug-disease risks, and documenting OASIS DRR findings. It also includes adherence checks, administration technique, and escalation steps when a discrepancy or safety issue is found. The template is designed for transitions of care where the medication list is often incomplete or outdated.

Use it at admission, resumption of care, recertification when medication status has changed, and after any hospital, ED, or specialist transition. It is also useful when a caregiver changes, a new high-risk medication is started, or the patient reports new symptoms that could be medication-related. If the medication list is stable and no transition has occurred, a lighter follow-up review may be enough, but the DRR still needs to be documented when required.

A licensed clinician responsible for the home health visit should complete it, typically a nurse or other qualified staff member within the agency workflow. The reviewer should be able to compare sources, identify discrepancies, and escalate concerns to the prescriber or pharmacist when needed. If the patient uses complex regimens, a pharmacist consult can be added, but the template still supports the bedside reconciliation performed by the home health team.

The template supports the medication reconciliation and drug regimen review expectations that home health agencies must document as part of their quality and assessment process. It also aligns with broader medication safety expectations from CMS, state surveyors, and standard care practices for transitions of care. It is not a substitute for agency policy, but it helps ensure the review is complete, traceable, and ready for audit.

Common misses include failing to compare the discharge list against what is actually in the home, overlooking OTC drugs and supplements, and leaving PRN medications without clear indications or limits. Another frequent issue is documenting the list without checking for duplicate therapy, allergies, or side effects that explain a recent decline. The template also helps prevent vague follow-up notes that do not show who was notified or what action was taken.

Yes. You can add sections for anticoagulants, insulin, opioids, inhalers, tube-feeding medications, or other high-risk therapies common in your patient mix. Agencies serving older adults, post-acute patients, or patients with cognitive impairment often add caregiver verification and pillbox review prompts. The structure should stay the same, but the medication risk prompts can be tailored to your service line.

Repeat it whenever the medication picture changes, not just on a fixed calendar. In home health, that usually means at admission, after transitions of care, when new symptoms appear, and after any medication change reported by the patient, caregiver, or prescriber. For patients with unstable regimens, frequent rechecks are appropriate because the home list can drift quickly from the prescribed list.

An ad hoc check often catches only the obvious list differences and leaves out interaction screening, adherence barriers, and documentation of escalation. This template creates a repeatable workflow so the reviewer checks the same sources, asks the same safety questions, and records the same follow-up actions every time. That consistency makes it easier to spot non-conformance, support continuity of care, and defend the review during audit.

It works best when paired with the discharge summary, physician orders, pharmacy fill history, prior home health notes, and the patient’s actual medication bottles or blister packs. If your workflow supports it, add EHR medication lists, allergy lists, and secure messaging or tasking to the prescriber or pharmacist. The template is strongest when it captures both what was reviewed and what source confirmed the final list.